Hong Kong Life Sciences and Technologies Group Limited provided earnings guidance for the three months ended 30 June 2020. For the period, the Group is expected to record a significant increase of approximately HKD 3.0 million in loss for the three months ended 30 June 2020 (the "Period") of approximately HKD 6.4 million as compared to the loss for the three months ended 30 June 2019 of approximately HKD 3.4 million.